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This study evaluated the action of ionizing radiation and the possible radioprotective effect 
of the non-steroidal anti-inflammatory drug meloxicam on the bone physiology of rat 
mandibles by assessing the alveolar socket healing and bone strength. Forty male Wistar rats 
were divided in 4 groups (n=10): control (CG), irradiated (IG), meloxicam (MG), meloxicam 
irradiated (MIG). A dose of 0.2 mg/kg meloxicam was administered to MG and MIG. After 
this, IG and MIG were irradiated with 15 Gy radiation dose in the mandible. Forty days 
after the above procedures, the mandibular first molars were extracted and the animals 
were killed after 15 or 30 days (n=5). Micro-computed tomography and bending test were 
used to evaluate alveolar socket healing and bone strength, respectively. At 15 days, bone 
volume, bone volume fraction and trabecular thickness were higher in the CG and MG 
than in the IG and MIG; and trabecular separation was higher in the IG compared with the 
others. At 30 days, there was a difference only in trabecular separation, which was higher 
in IG than in CG and MG, and MIG did not differ from the others. Bone strength was lower 
in IG compared with CG and MG, and MIG did not differ from the others. In conclusion, 
the ionizing radiation affected the bone physiology of rat mandibles, delaying the alveolar 
socket healing and reducing the bone strength. Moreover, the meloxicam had a positive 
effect on the trabecular separation in alveolar socket healing and on the bone strength.
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Introduction
Radiotherapy is an important and traditional therapy in 
the treatment of head and neck cancer. However, despite 
ongoing research on new radiotherapy protocols, ionizing 
radiation invariably has some side effects on normal cells, 
resulting in acute and delayed oral complications. Acute 
oral complications generally develop within 90 days after 
beginning of radiotherapy and the most common are 
mucositis, dermatitis, taste alterations and dry mouth. 
Delayed oral complications usually occur after 90 days, and 
may include chronic xerostomia, difficulties with chewing, 
swallowing and speaking, fibrosis, trismus, atrophy, as 
well as increased susceptibility to oral infections, dental 
caries, periodontal diseases and osteoradionecrosis. These 
oral complications have a negative impact on the quality 
of life and must be considered before, during and after 
radiotherapy(1,2).
Although both the acute and delayed oral complications 
have the same trigger, their development occurs by different 
processes. The occurrence of the acute oral complications 
is related to loss of reproductive integrity and cell death 
caused directly by ionizing radiation due to the formation of 
free radicals. Regarding the delayed oral complications, the 
most recent theory is based on changes in tissue physiology 
due to a fibroatrophy process induced by ionizing radiation. 
According to this theory, initially there is non-specific 
chronic local inflammation in the tissues, leading to necrosis 
of microvessels and local ischemia, followed by a progressive 
increase of fibrotic tissue in the region. In the irradiated 
bone tissue, the result of fibroatrophy process is shown by 
fibrosis of the marrow spaces and periosteum, along with a 
reduction in vascularity, which decreases the transport of 
nutrients and white blood cells. Consequently, the rate of 
cell death increases, impairing bone remodeling and healing, 
and the susceptibility to bone infections also increases. The 
main implication of the different development processes of 
the oral complications is the fact that when radiotherapy 
has finished, the acute ones are generally reversible while 
the delayed ones induce permanent tissue changes (2-4).
In order to mitigate oral complications, many radiation-
protective agents have been studied with the aim of 
reducing the side effects due to radiotherapy on normal 
cells (5-11). Possible radioprotective effects of non-steroidal 
anti-inflammatory drugs (NSAIDs) have been researched 
recently and positive results have been observed(5, 6, 
10). The ionizing radiation used in radiotherapy induces 
inflammation mediators in normal tissues, especially 
by activation of cyclooxygenase 2 (Cox-2) and damage 
may occur (5), thus justifying the research on NSAIDs as 
radiation-protective agents.
Apart from the consequences of the bone physiology 
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changes due to radiotherapy, it is important to research 
the possible effect of radiation-protective agents on its 
occurrence. Even though the changes in bone physiology 
may be related to an inflammatory process of the bone 
tissues induced by ionizing radiation, the effect of NSAIDs 
on it has not yet been studied. Therefore, this experimental 
animal model was proposed in order to evaluate the action 
of ionizing radiation and the possible radioprotective effect 
of the NSAID meloxicam on the bone physiology of rat 
mandibles by assessing the alveolar socket healing and 
the bone strength.
Material and Methods
The study protocol was first approved by the Local Ethics 
Committee on Animal Use. Forty male Wistar rats, 75 days 
old and weighing around 350 g, were used. The animals 
were maintained in a room at a controlled temperature 
and relative humidity, in a light/dark cycle of 12 h, on a 
standard pelleted rodent diet and water ad libitum.
The animals were randomly divided into 4 experimental 
groups (n=10) according to meloxicam administration and 
radiation delivery: control group (CG), without meloxicam 
administration nor radiation; irradiated group (IG), without 
meloxicam administration and delivery of radiation; 
meloxicam group (MG), with meloxicam administration 
and no radiation; meloxicam irradiated group (MIG), with 
both meloxicam administration and radiation.
When the animals were 75 days old, they were 
anaesthetized with a single intramuscular injection 
of 100 mg/kg ketamine (Dopalen, Ceva Saúde Animal, 
Paulínia, SP, Brazil) and 10 mg/kg xylazine (Rompun, 
Bayer S.A., São Paulo, SP, Brazil). Then, a single dose of 
0.2 mg/kg meloxicam (Maxicam, Ouro Fino Saúde Animal, 
Cravinhos, SP, Brazil), as indicated by the manufacturer, was 
administered intraperitoneally to the animals in the MG and 
MIG groups. After 1 h(5, 6), the animals in the IG and MIG 
groups were irradiated with a single 15 Gy radiation dose 
in the mandible region using a linear accelerator (Clinic 
6/100®, Varian Medical Systems, Palo Alto, CA, USA), with 
a 100 cm focal length and a 15x30 cm collimation field. 
The animals were positioned with only their head and neck 
region in the radiation field. Moreover, in order to expose 
all the animals to the same stimuli and stresses, they were 
all anaesthetized and distilled water was administered to 
animals in the CG and IG groups instead of meloxicam.
Forty days after delivery of radiation(12), the animals 
were anaesthetized again and placed in a holder to keep 
their mouth open for the bilateral extraction of the first 
molars, which was done using the Hollenback dental 
instrument (Duflex®, S.S. White, Rio de Janeiro, RJ, Brazil). 
The animals were killed with an anesthesia overdose, half 
at 15 days after tooth extraction (n=5) and the other half 
at 30 days after tooth extraction (n=5). Gingival healing 
and the presence of a fistula in the region of the extracted 
mandibular first molars were evaluated macroscopically 
before removing the hemimandibles, which were immersed 
for 72 h in 10% buffered formalin and stored in saline 
solution in a refrigerator until use.
One hemimandible from each animal was used to 
evaluate alveolar socket healing by micro-computed 
tomography (micro-CT). Initially, each hemimandible was 
vertically and centrally positioned in a receptacle with 
water inside the micro-CT scanner (SkyScan 1174; SkyScan, 
Kontich, Belgium) and the images were acquired using the 
following parameters: 50 kV, 800 µA, 9.47 µm pixel size, 
0.45º rotation step, 180º total rotation, 3 frames and 0.5 
mm aluminum filter. The images were reconstructed using 
NRecon software (SkyScan) with the following parameters: 
700 sections, 1 for smoothing, 5 for ring artefact reduction, 
10% of beam-hardening correction and a histogram with a 
dynamic range of 0.01–0.12. DataViewer software (SkyScan) 
was used to adjust the images of the hemimandibles in 
order to get better positioning of the distal tooth socket 
of the extracted mandibular first molar. The images were 
then evaluated using CTAn software (SkyScan) and only the 
sections including the distal tooth socket of the extracted 
mandibular first molar were selected to manually delineate 
the area showing alveolar socket healing. A global threshold 
ranging from 25 to 65 and from 25 to 80 was established 
for the hemimandibles of animals killed at 15 and 30 days 
after tooth extraction, respectively. Then, three-dimensional 
analysis of the region of interest was performed to examine 
the features of the trabecular bone microarchitecture, 
according to Bouxsein et al.(13), like total volume, bone 
volume, bone volume fraction (bone volume/total volume), 
trabecular number, trabecular thickness and trabecular 
separation.
The other hemimandible from each animal was used 
in the three-point bending test to evaluate bone strength. 
Each one was placed perpendicularly with the lateral surface 
on 2 vertical bars of the metal support in a material-testing 
machine (Instron 4411; Instron, Norwood, MA, USA) with 
the insert centred between the bars and oriented over the 
molars of the hemimandible (Fig. 1). The insert deflected 
the hemimandible at a constant speed of 1 mm/min until 
it fractured and the peak load values representing bone 
strength were obtained in Newton (N).
Data variables from the micro-CT three-dimensional 
analysis and the bending test were expressed as mean ± 
standard deviation. The results were analyzed and compared 
by one-way analysis of variance (ANOVA) followed by 
post hoc comparisons with the Tukey test, using IBM SPSS 
Statistics 22.0 (IBM Corp, Armonk, NY, USA). Statistical 
significance was set at p<0.05. The null hypothesis under 
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consideration was the absence of a significant statistical 
difference between the experimental groups.
Results
Macroscopic evaluation of the region of the extracted 
mandibular first molars before removing the hemimandibles 
showed complete gingival healing and no fistula in all 
animals.
The alveolar socket healing was in the intermediate 
stage at 15 days after tooth extraction and in the final 
stage, but not complete, at 30 days. Tables 1 and 2 
present the data on the features of the trabecular bone 
microarchitecture of alveolar socket healing for each 
group. At 15 days after tooth extraction (Fig. 2), total 
volume (p=0.308) and trabecular number (p=0.060) did 
not differ statistically between the groups; bone volume 
(p<0.001), bone volume fraction (p<0.001) and trabecular 
thickness (p<0.001) were significantly higher in the CG 
and MG groups than in the IG and MIG groups; trabecular 
separation (p<0.001) was significantly higher in the IG 
group in comparison with the other groups. At 30 days 
after tooth extraction (Fig. 2), there was no statistical 
difference among the groups concerning total volume 
(p=0.940), bone volume (p=0.943), bone volume fraction 
(p=0.513), trabecular number (p=0.204) and trabecular 
thickness (p=0.299). However, trabecular separation 
(p=0.019) was significantly higher in the IG group than in 
the CG and MG groups and the MIG group did not differ 
statistically from the others.
Regarding hemimandible bone strength, as presented 
in Table 3, the values for the IG group were significantly 
lower compared with the CG and MG groups (p=0.006), and 
the MIG group did not differ statistically from the others.
Discussion
Changes in bone physiology are one of the oral 
complications due to radiotherapy, and it may trigger 
more severe oral complications, like osteoradionecrosis. 
Thus, it is important study it and for this, use of 
experimental animal models is necessary(14,15). Earlier 
studies were done to develop an induction model of 
osteoradionecrosis in animals by causing changes in 
bone physiology with ionizing radiation(12,14-18); 
however, none of these studies focused at preventing its 
occurrence. In addition, although other studies evaluated 
the possible effects of radiation-protective agents on 
ionizing radiation damage(5-11), they tested the agents 
on acute complications and none correlated to delayed 
complications. Consequently, this study may be considered 
pioneering in the search for radiation-protective agents 
relative to extensive changes in irradiated bone.
It is worth mentioning that bone physiology could not 
be directly evaluated, since it is a dynamic process that 
refers to how the bone is working. In contrast, there are 
many methods to evaluate indirectly its response, among 
which was chosen the assessment of alveolar socket 
healing and bone strength, which are highly associated to 
clinical aspects concerning to possible tooth extractions 
and to bone fractures susceptibility, respectively. Moreover, 
regarding the evaluation of alveolar socket healing by 
micro-CT, no values for trabecular bone microarchitecture 
features were reported in previous studies in relation 
to trabecular analysis of alveolar socket healing in rats, 
whether irradiated or not. Thus, the values obtained in 
this study may be a reference for further studies.
In the present study, as in others(12,17), was chosen to 
use external irradiation, similar to the standard protocol 
for head and neck radiotherapy. The region chosen for 
irradiation was the mandible, because it is more susceptible 
to osteoradionecrosis than the hind limbs in animals (15); 
thus, lower radiation doses had to be used because the 
head and neck region has more radiosensitive tissues and 
a high radiation dose could induce early mortality of the 
animals(17). With regard to the fractionate irradiation 
protocol, although it is recommended in head and neck 
radiotherapy, its execution is complex in experimental 
animal models as it requires multiple irradiations and 
repeated anesthesia, which is undesirable, because it makes 
reproducing the study more difficult and decreases the 
probability of the animal survival(4, 14, 16).
Therefore, a single dose of 15 Gy radiation was 
used in this study. According to the linear-quadratic 
model(19) and considering the α/β ratio, which quantifies 
the fractionation radiosensitivity of tissues, equals 2 
for bone (12), a single dose of 15 Gy is equivalent to a 
total dose of about 64 Gy in a regimen with multiple 
2 Gy fractions as used in the standard protocol for 
head and neck radiotherapy. In addition, the total dose 
of 64 Gy is compatible with the minimum radiation 
dose (60 Gy) needed to enable the development of Figure 1. Positioning of the sample for the bending test.
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osteoradionecrosis(1,3,12).
In order to simulate the situation in which a patient 
must have a tooth extracted sometime after radiotherapy, 
tooth extraction was performed on the animals, similar to 
others studies(14, 18, 20). However, unlike those studies, it 
was chosen to perform it 40 days after the animals received 
irradiation, a period sufficient to reveal histological 
changes in bone tissue in mandibles of irradiated rats(12), 
and because tooth extraction is contraindicated during 
treatment.
The macroscopic evaluation in the present study 
showed complete gingival healing and absence of fistula 
in tooth extraction regions in all animals, suggesting 
absence of clinical osteoradionecrosis. Lerouxel et al.(17) 
and Fenner et al.(12) were also unable to induce clinical 
osteoradionecrosis, but they noted histological changes in 
irradiated bone tissue. Similarly, this study found that the 
bone physiology was altered by ionizing radiation, which 
is evident from the delay in alveolar socket healing at 15 
days after tooth extraction and the lower bone strength 
Table 1. Mean and standard deviation of trabecular bone 
microarchitecture data regarding volume analysis for each group
Group
Total volume
(mm³)
Bone volume
(mm³)
Bone volume 
fraction
(%)
15 
days
CG 1.96±0.28 a 1.46±0.19 a 75.30±7.69 a
IG 2.08±0.11 a 0.83±0.17 b 40.01±8.22 b
MG 1.84±0.22 a 1.40±0.18 a 76.38±5.40 a
MIG 2.02±0.12 a 0.94±0.16 b 46.98±9.98 b
30 
days
CG 1.68±0.09 a 1.35±0.13 a 80.01±7.94 a
IG 1.71±0.25 a 1.30±0.21 a 75.85±5.67 a
MG 1.59±0.51 a 1.23±0.56 a 75.23±9.74 a
MIG 1.64±0.30 a 1.34±0.29 a 81.40±6.53 a
Control group (CG); irradiated group (IG); meloxicam group (MG); 
meloxicam irradiated group (MIG). Means followed by different letters 
in the same column are significantly different, according to ANOVA 
and the Tukey test.
Figure 2. Region of healing in the alveolar socket at 15 days (A–D) and 30 days (E–H) after tooth extraction. A, E: Control group; B, F: irradiated 
group; C, G: meloxicam group; D, H: meloxicam irradiated group.
Table 2. Mean and standard deviation of trabecular bone 
microarchitecture data regarding trabecular analysis for each group
Group
Trabecular 
number
(1/mm)
Trabecular 
thickness
(mm)
Trabecular 
separation
(mm)
15 
days
CG 3.73±0.22 a 0.20±0.03 a 0.16±0.05 a
IG 3.70±0.43 a 0.11±0.02 b 0.34±0.04 b
MG 4.43±0.53 a 0.17±0.03 a 0.16±0.04 a
MIG 4.22±0.59 a 0.11±0.01 b 0.25±0.06 a
30 
days
CG 5.28±1.02 a 0.16±0.05 a 0.10±0.02 a
IG 3.95±1.28 a 0.21±0.05 a 0.22±0.11 b
MG 4.91±1.30 a 0.17±0.08 a 0.11±0.01 a
MIG 3.80±1.32 a 0.23±0.06 a 0.14±0.04 ab
Control group (CG); irradiated group (IG); meloxicam group (MG); 
meloxicam irradiated group (MIG). Means followed by different letters 
in the same column are significantly different, according to ANOVA 
and the Tukey test.
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in the IG group compared with the CG group.
The total volume was similar in all groups, 
demonstrating that the delimited area of alveolar socket 
healing for the micro-CT three-dimensional analysis was 
equivalent. It also was observed that alveolar socket 
healing was clearly delayed by ionizing radiation at 15 
days after tooth extraction but not at 30 days, suggesting 
that it is more affected in the intermediate stage than 
in the final stage. In the study by Cohen et al. (18), the 
numerical difference in bone volume fraction between the 
irradiated group and the control group at 28 days after 
tooth extraction was lower than the same difference at 
21 days after tooth extraction in the study by Tamplen 
et al. (14), although a higher radiation dose was used 
in the former study. Considering the disparities in the 
methodologies, this could support the idea that the final 
stage of the alveolar socket healing is less influenced by 
ionizing radiation. Furthermore, the trabecular separation 
was the only feature of trabecular bone microarchitecture 
that remained altered in the GI group at 30 days after 
tooth extraction, which suggests that the non-mineralized 
portion of the alveolar socket in irradiated bone is more 
affected than the mineralized portion. Regarding the 
interpretation of the data, it must be emphasized that 
the trabecular separation is the only one where a lower 
value is desired in a normal alveolar socket healing, unlike 
the other parameters of bone trabecular microstructure, 
which must be higher (13).
Bone strength was reduced in the IG group compared 
with the CG group. According to Nyaruba et al. (21) and 
Wernle et al. (22), alterations in bone strength seem to 
be more related to changes in the trabecular morphology 
than in the cortical morphology of irradiated bone. 
Nevertheless, the influence of ionizing radiation on the 
mechanical properties of bone was not yet fully clarified, 
as there are conflicting reports in previous studies(11, 
21-23). In addition, the micro-CT images (Fig. 2) show 
changes in the incisor morphology of the animals in the 
IG group compared with the CG group. This is possibly due 
to changes of ionizing radiation in the odontogenic region 
(24), which may have contributed to the decrease in bone 
strength in the hemimandibles of the irradiated animals.
In search to reduce bone damage due to irradiation, 
Rocha et al.(8) and Freitas et al. (9) observed a 
radioprotective effect of sodium selenite on bone healing 
in rat tibia, and Felice et al. (11) noted radioprotective 
effects of amifostine on bone strength in rat mandible. 
However, in this study as in others (5-7), was chosen 
to evaluate the NSAID meloxicam as a radiation-
protective agent. The great advantage of researching the 
radioprotective effect of NSAIDs is that these drugs are 
widely studied, even if not for this specific purpose, and 
their bioavailability, pharmacokinetics and side effects 
are well known(10). Moreover, it has been suggested that 
COX-2 inhibition may contribute to control of cancer 
progression and prevention of metastasis (25). Thus, 
the administration of NSAIDs could contribute both to 
mitigate oral complications due to radiotherapy and to 
aid cancer treatment.
Recently, sodium diclofenac, a classic NSAID, was found 
to have radioprotective effect on animal survival and on 
reduction of free radicals and damage to the genetic code 
of cells after irradiation (10); nevertheless, classic NSAIDs 
may induce side effects, mainly gastrointestinal ones (7). 
Furthermore, meloxicam, a COX-2-selective NSAID, has 
also been shown to have an efficient radioprotective 
effect on animal survival with administration of a single 
dose before irradiation (6), and on improvement of 
hematopoiesis with administration of a single dose before 
irradiation and of multiple doses after irradiation (5,6). The 
radioprotective effect on hematopoiesis was not detected 
only when a single dose of meloxicam was administered 
after irradiation (7).
It is noteworthy that if meloxicam is used as a 
radiation-protective agent its aim is to mitigate the 
changes in the irradiated bone, since the fibroatrophy 
process induced by ionizing radiation has an initial phase 
based on a non-specific chronic local inflammation (4). 
Thus, meloxicam was administrated immediately before 
the irradiation in order to act in the inflammatory process 
triggered by ionizing radiation. It is also important to 
emphasize that a direct action of the meloxicam on the 
alveolar socket healing is unlikely, because its half-life is 
around 24 h and the tooth extraction was performed 40 
days after its application. Therefore, the alveolar socket 
healing is only related to the bone physiologic response.
Meloxicam did not damage trabecular bone 
microarchitecture and bone strength and it significantly 
improved trabecular separation at 15 days after tooth 
extraction. Trabecular separation at 30 days after tooth 
Table 3. Mean and standard deviation (SD) of bone strength data 
(N) for each group
Group Mean±SD
CG 92.71±13.64 a
IG 71.38±10.07 b
MG 91.68±18.32 a
MIG 82.83±13.03 ab
Control group (CG); irradiated group (IG); meloxicam group (MG); 
meloxicam irradiated group (MIG). Means followed by different letters 
in the same column are significantly different, according to ANOVA 
and the Tukey test.
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extraction and bone strength were positively influenced by 
meloxicam. With regard to the clear radioprotective effect 
observed by Hofer et al. (5,6), the results of the present 
study fell short of their results, which may be explained by 
the lower dose of meloxicam used in this study (0.2 mg/kg 
compared with 20 mg/kg). This choice was made based on 
the interest of investigating the influence of the clinically 
established loading dose. However, as mentioned above, 
these results may contribute to the idea that the trabecular 
bone morphology, especially the non-mineralized portion, 
appears to be more affected by changes in irradiated bone 
and therefore more favored by meloxicam.
Few studies were found about the possible effect of 
radiation-protective agents on the bone physiology by 
assessing the alveolar socket healing and the bone strength, 
which compromises comparison and validation of the 
results of this study. With regard to meloxicam, although the 
results were not ideal, in view of the radioprotective effect 
demonstrated in previous studies and the improvement in 
trabecular separation of trabecular bone microarchitecture 
of alveolar socket healing and in bone strength in this 
study, the authors still believe that meloxicam may be an 
efficient radiation-protective agent in relation to changes 
in physiology of irradiated bone. Consequently, further 
studies are required.
In conclusion, the ionizing radiation affected the bone 
physiology of rat mandibles, delaying the alveolar socket 
healing and reducing the bone strength. Meloxicam, even 
though it has not demonstrated a strong radioprotective 
effect in the bone physiology of rat mandibles, had a 
positive effect on the trabecular separation of trabecular 
bone microarchitecture in alveolar socket healing and on 
the bone strength.
Resumo
Este estudo avaliou a ação da radiação ionizante e o possível efeito 
radioprotetor do anti-inflamatório não esteroide meloxicam na fisiologia 
óssea de mandíbulas de rato por meio da análise da reparação alveolar e 
da resistência óssea. Quarenta ratos Wistar machos foram divididos em 4 
grupos (n=10): controle (GC), irradiado (GI), meloxicam (GM), meloxicam 
irradiado (GMI). Administrou-se uma dose única de 0,2 mg/kg de meloxicam 
no GM e GMI. Posteriormente, o GI e GMI foram irradiados com dose de 15 
Gy na região de mandíbula. Decorridos 40 dias dos procedimentos acima, 
extraiu-se os primeiros molares inferiores dos animais, que foram mortos 
após 15 e 30 dias (n=5). Utilizou-se a microtomografia computadorizada 
e o teste de flexão para avaliação da reparação alveolar e da resistência 
óssea, respectivamente. Aos 15 dias, o volume ósseo, a fração de volume 
ósseo e a espessura trabecular foram maiores no GC e GM comparados 
ao GI e GMI; já a separação trabecular foi maior no GI em relação aos 
demais. Aos 30 dias, houve diferença apenas na separação trabecular, que 
foi maior no GI em comparação ao GC e GM, não tendo o GMI diferido dos 
demais. A resistência óssea no GI foi menor em relação ao GC e GM, não 
tendo o GMI diferido dos demais. Concluiu-se que a radiação ionizante 
afetou a fisiologia óssea das mandíbulas de rato, promovendo atraso na 
reparação alveolar e redução da resistência óssea; além disso, o meloxicam, 
apresentou efeito positivo na separação trabecular da reparação alveolar 
e na resistência óssea.
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